NSP INSPERITY, INC.

NYSE insperity.com


$ 34.22 $ 1.39 (4.23 %)    

Tuesday, 11-Nov-2025 15:59:54 EST
QQQ $ 623.78 $ 0.00 (0 %)
DIA $ 479.94 $ 0.00 (0 %)
SPY $ 684.19 $ 0.00 (0 %)
TLT $ 89.68 $ 0.00 (0 %)
GLD $ 379.49 $ 0.00 (0 %)
$ 34.22
$ 33.36
$ 34.05 x 44
$ 36.00 x 3
-- - --
$ 32.62 - $ 93.40
897,908
na
1.29B
$ 0.89
$ 75.90
TBD
na
na ($ 0.07)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-04-2025 09-30-2025 10-Q
2 08-01-2025 06-30-2025 10-Q
3 04-29-2025 03-31-2025 10-Q
4 02-11-2025 12-31-2024 10-K
5 10-31-2024 09-30-2024 10-Q
6 08-06-2024 06-30-2024 10-Q
7 05-01-2024 03-31-2024 10-Q
8 02-09-2024 12-31-2023 10-K
9 10-31-2023 09-30-2023 10-Q
10 08-01-2023 06-30-2023 10-Q
11 04-26-2023 03-31-2023 10-Q
12 02-10-2023 12-31-2022 10-K
13 10-31-2022 09-30-2022 10-Q
14 08-01-2022 06-30-2022 10-Q
15 04-26-2022 03-31-2022 10-Q
16 02-10-2022 12-31-2021 10-K
17 11-01-2021 09-30-2021 10-Q
18 08-03-2021 06-30-2021 10-Q
19 05-04-2021 03-31-2021 10-Q
20 02-12-2021 12-31-2020 10-K
21 11-02-2020 09-30-2020 10-Q
22 08-04-2020 06-30-2020 10-Q
23 05-05-2020 03-31-2020 10-Q
24 02-12-2020 12-31-2019 10-K
25 11-04-2019 09-30-2019 10-Q
26 07-29-2019 06-30-2019 10-Q
27 04-29-2019 03-31-2019 10-Q
28 02-11-2019 12-31-2018 10-K
29 11-01-2018 09-30-2018 10-Q
30 08-01-2018 06-30-2018 10-Q
31 04-30-2018 03-31-2018 10-Q
32 02-12-2018 12-31-2017 10-K
33 11-01-2017 09-30-2017 10-Q
34 08-01-2017 06-30-2017 10-Q
35 05-01-2017 03-31-2017 10-Q
36 02-13-2017 12-31-2016 10-K
37 11-01-2016 09-30-2016 10-Q
38 08-01-2016 06-30-2016 10-Q
39 05-02-2016 03-31-2016 10-Q
40 02-12-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 truist-securities-maintains-hold-on-insperity-lowers-price-target-to-35

Truist Securities analyst Tobey Sommer maintains Insperity (NYSE:NSP) with a Hold and lowers the price target from $50 to $35.

Core News & Articles

PRLD: 70% | Prelude Therapeutics Signs Agreement For Incyte To Acquire JAK2V617F JH2 Inhibitor Program In Development For Patie...

Core News & Articles

On November 3, 2025, a subsidiary of Insperity, Inc. (the "Company") entered into an amendment to its arrangement with ...

 insperity-sees-q4-gaap-eps-107-044-vs-018-est

Insperity (NYSE:NSP) is looking for Q4 GAAP EPS of $(1.07)-$(0.44) vs $(0.18) analyst estimate..

 insperity-lowers-fy2025-gaap-eps-guidance-from-059-129-to-038-025-vs-101-est

Insperity (NYSE:NSP) lowers FY2025 GAAP EPS guidance from $0.59-$1.29 to $(0.38)-$0.25 vs $1.01 analyst estimate..

 insperity-lowers-fy2025-adj-eps-guidance-from-181-251-to-084-147-vs-211-est

Insperity (NYSE:NSP) lowers FY2025 Adj EPS guidance from $1.81-$2.51 to $0.84-$1.47 vs $2.11 analyst estimate..

 insperity-sees-q4-adj-eps-079-016-vs-008-est

Insperity (NYSE:NSP) is looking for Q4 Adj EPS of $(0.79)-$(0.16) vs $0.08 analyst estimate..

 insperity-q3-adj-eps-020-misses-022-estimate-sales-1623b-miss-1632b-estimate

Insperity (NYSE:NSP) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $0.22 by 189...

 insperity-announces-dual-listing-of-its-common-stock-on-nyse-texas

Insperity, Inc. (NYSE:NSP), a leading provider of human resources and business performance solutions, today announced the dual ...

 roth-capital-maintains-buy-on-insperity-lowers-price-target-to-74

Roth Capital analyst Jeff Martin maintains Insperity (NYSE:NSP) with a Buy and lowers the price target from $85 to $74.

 jp-morgan-maintains-underweight-on-insperity-lowers-price-target-to-51

JP Morgan analyst Andrew Polkowitz maintains Insperity (NYSE:NSP) with a Underweight and lowers the price target from $68 to...

 truist-securities-maintains-hold-on-insperity-lowers-price-target-to-50

Truist Securities analyst Tobey Sommer maintains Insperity (NYSE:NSP) with a Hold and lowers the price target from $70 to $50.

 insperity-lowers-fy2025-adj-eps-guidance-from-223-328-to-181-251-vs-248-est

Insperity (NYSE:NSP) lowers FY2025 Adj EPS guidance from $2.23-$3.28 to $1.81-$2.51 vs $2.48 analyst estimate..

 insperity-sees-q3-adj-eps-006-049-vs-032-est

Insperity (NYSE:NSP) is looking for Q3 Adj EPS of $0.06-$0.49 vs $0.32 analyst estimate..

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION